FDA Recommendations for User Fee Programs Sent to Congress

The agency proposed three user fee programs to Congress earlier this month.

Our Take: The programs include the fifth authorization of the original Prescription Drug User Fee Act (PDUFA) as well as the new generic and biosimilar programs. The recommendation were sent to Congress, but there's been little published to date about their status. We'll keep you posted as they are considered and information becomes available.